Skip to menu Skip to content Skip to footer
Professor Mark Smithers
Professor

Mark Smithers

Email: 

Overview

Background

Emeritus Professor Mark Smithers is a surgical oncologist who specialises in surgery for oesophago-gastric diseases, melanoma, advanced skin cancer and soft tissue sarcoma. He was the Director of the Upper GI and Soft Tissue Unit at the Princess Alexandra Hospital, in Brisbane, Australia from 1998 - 2023. Commencing his academic career with the University of Queensland in 1987, he progressed to be the Mayne Chair in Surgery and head of the Academy of Surgery. He is the second University of Queensland Medical graduate to be appointed to this role. His research has been focussed on the development and assessment of outcomes from minimally invasive upper GI surgery, and trials assessing the role of perioperative multidisciplinary therapy for esophageal and gastric cancer. As well he has led, or been involved with, clinical trials from phase I to III, for all stages of melanoma through his role as the Chair of the Queensland Melanoma Project. More recently he has been involved with the assessment of access to, and outcomes from, surgery for cancer in Queensland, Australia.

He has overseen the administration and development of the surgery curriculum, and the teaching, in the Academy of Surgery, in the UQ Faculty of Medicine. He was on a number of committees relevant to the implementation of the UQ MD design course. He has held various leadership and committee roles with the Royal Australasian College of Surgeons, as well as leadership roles, including the Presidency, in the Australian and New Zealand Oesophago Gastric Surgeons Association. He has also been on the committees of international organisations related to oesophageal and gastric surgery. He has published 250 articles, eight book chapters, and has been on the editorial board of a number of surgical journals.

He has been recognised for his clinical and academic roles by the award of Member of the Order of Australia (AM). The citation reads, "for service to medicine in the fields of gastro-intestinal and melanoma surgery, to medical education and to professional organisations". The Royal Australasian College of Surgeons awarded him the Sir Hugh Devine medal, for services to surgery and the community. This is the College’s highest honour. Internationally, he has been awarded an honorary fellowship of the Royal College of Surgeons of Edinburgh and recently, in the United States, he was elected as an Honarary Fellow of the American Surgical Association.

Availability

Professor Mark Smithers is:
Not available for supervision
Media expert

Qualifications

  • Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
  • Honorary Fellow, American Surgical Association, American Surgical Association
  • Fellow, Royal Australasian College of Surgeons, Royal Australasian College of Surgeons
  • Fellow, Royal College of Surgeons of Edinburgh, Royal College of Surgeons of Edinburgh
  • Fellow, Royal College of Surgeons of England, Royal College of Surgeons of England

Research interests

  • Cutaneous Melanoma

    epidemiology, public health issues and management of all stages

  • Management of Oesophageal and Gastric Cancer

    Investigation and management of benign and malignant diseases of the oesophagus and the stomach.

Works

Search Professor Mark Smithers’s works on UQ eSpace

410 works between 1983 and 2025

141 - 160 of 410 works

2018

Journal Article

Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagus

Effeney, R., Shaw, T., Burmeister, B. H., Burmeister, E., Harvey, J., Mai, G. T., Thomas, J., Barbour, A. P., Smithers, B. M. and Pryor, D. I. (2018). Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagus. Clinical Oncology, 30 (10), 642-649. doi: 10.1016/j.clon.2018.06.011

Patterns of failure following dose-escalated chemoradiotherapy for fluorodeoxyglucose positron emission tomography staged squamous cell carcinoma of the oesophagus

2018

Journal Article

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

Dreno, Brigitte, Thompson, John F., Smithers, Bernard Mark, Santinami, Mario, Jouary, Thomas, Gutzmer, Ralf, Levchenko, Evgeny, Rutkowski, Piotr, Grob, Jean-Jacques, Korovin, Sergii, Drucis, Kamil, Grange, Florent, Machet, Laurent, Hersey, Peter, Krajsova, Ivana, Testori, Alessandro, Conry, Robert, Guillot, Bernard, Kruit, Wim H. J., Demidov, Lev, Thompson, John A., Bondarenko, Igor, Jaroszek, Jaroslaw, Puig, Susana, Cinat, Gabriela, Hauschild, Axel, Goeman, Jelle J., van Houwelingen, Hans C., Ulloa-Montoya, Fernando ... Kirkwood, John M. (2018). MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Oncology, 19 (7), 916-929. doi: 10.1016/S1470-2045(18)30254-7

MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

2018

Journal Article

Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus

Visser, Els, Edholm, David, Smithers, B. Mark, Thomson, Iain G., Burmeister, Bryan H., Walpole, Euan T., Gotley, David C., Joubert, Warren L., Atkinson, Victoria, Mai, Tao, Thomas, Janine M. and Barbour, Andrew P. (2018). Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus. Journal of Surgical Oncology, 117 (8), 1687-1696. doi: 10.1002/jso.25089

Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus

2018

Journal Article

Clustering of prevention behaviours in patients with high-risk primary melanoma

Green, Adèle C., Hughes, Maria Celia B., von Schuckmann, Lena A., Khosrotehrani, Kiarash and Mark Smithers, B. (2018). Clustering of prevention behaviours in patients with high-risk primary melanoma. Psycho-Oncology, 27 (5), 1442-1449. doi: 10.1002/pon.4565

Clustering of prevention behaviours in patients with high-risk primary melanoma

2018

Journal Article

Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy

Thomson, Iain G., Wallen, Matthew P., Hall, Adrian, Ferris, Rebekah, Gotley, David C., Barbour, Andrew P., Lee, Andrew, Thomas, Janine and Smithers, Bernard M. (2018). Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy. International Journal of Surgery, 53, 86-92. doi: 10.1016/j.ijsu.2018.03.030

Neoadjuvant therapy reduces cardiopulmunary function in patients undegoing oesophagectomy

2018

Journal Article

Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study

Read, Tavis A., Smith, Aaron, Thomas, Janine, David, Michael, Foote, Matthew, Wagels, Michael, Barbour, Andrew and Smithers, B. Mark (2018). Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study. Journal of Surgical Oncology, 117 (4), 579-587. doi: 10.1002/jso.24921

Intralesional PV-10 for the treatment of in-transit melanoma metastases-Results of a prospective, non-randomized, single center study

2018

Journal Article

Future-proofing academic surgery in Australia and New Zealand: the Annual RACS Joint Academic Meeting

Aitken, Sarah, Lee, James and Smithers, Mark (2018). Future-proofing academic surgery in Australia and New Zealand: the Annual RACS Joint Academic Meeting. ANZ Journal of Surgery , 88 (3), 130-131. doi: 10.1111/ans.14372

Future-proofing academic surgery in Australia and New Zealand: the Annual RACS Joint Academic Meeting

2018

Journal Article

An investigation into the nutritional status of patients receiving an Enhanced Recovery After Surgery (ERAS) protocol versus standard care following Oesophagectomy

Benton, Katie, Thomson, Iain, Isenring, Elisabeth, Mark Smithers, B. and Agarwal, Ekta (2018). An investigation into the nutritional status of patients receiving an Enhanced Recovery After Surgery (ERAS) protocol versus standard care following Oesophagectomy. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, 26 (6), 1-6. doi: 10.1007/s00520-017-4038-4

An investigation into the nutritional status of patients receiving an Enhanced Recovery After Surgery (ERAS) protocol versus standard care following Oesophagectomy

2018

Conference Publication

Effect of a previous diagnosis of primary invasive melanoma on the progression of subsequent primary invasive melanoma

Chong, S., Green, A., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2018). Effect of a previous diagnosis of primary invasive melanoma on the progression of subsequent primary invasive melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 19-22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.17_12815

Effect of a previous diagnosis of primary invasive melanoma on the progression of subsequent primary invasive melanoma

2018

Conference Publication

Oncolytic immunotherapy with PV-10

Agarwala, Sanjiv, Smithers, B. Mark, Haushild, Axel, Ascierto, Paolo A. and Watcher, Eric (2018). Oncolytic immunotherapy with PV-10. Immunotherapy Bridge 2017, Naples, Italy, 29 November - 2 December 2017. London, United Kingdom: BioMed Central. doi: 10.1186/s12967-017-1352-z

Oncolytic immunotherapy with PV-10

2018

Conference Publication

Overview of melanoma genetics for dermatologists and results of a genetic analysis of multiple primary melanoma patients

MoMeniman, E., Sturm, R., Duffy, D., Jagirdar, K., Lee, K., Finnane, A., De'Ambrosis, B., Smithers, M. and Soyer, H. P. (2018). Overview of melanoma genetics for dermatologists and results of a genetic analysis of multiple primary melanoma patients. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, Australia, 19–22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/ajd.14_12815

Overview of melanoma genetics for dermatologists and results of a genetic analysis of multiple primary melanoma patients

2018

Book Chapter

Thoracoscopic and laparoscopic esophagectomy

Smithers, B. Mark, Thomson, Iain and Barbour, Andrew (2018). Thoracoscopic and laparoscopic esophagectomy. Operative thoracic surgery. (pp. 377-386) edited by Larry R. Kaiser, Sarah K. Thompson and Glyn G. Jamieson. Boca Raton, FL, United States: CRC Press. doi: 10.1201/9781315113777

Thoracoscopic and laparoscopic esophagectomy

2018

Conference Publication

Neoadjuvant therapy for esophageal adenocarcinoma: a propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapy

Barbour, A. P., Brosda, S., Wijnhoven, B., van Hootgem, S., Lanschot, J. J. B., Barbour, S., Lagarde, S., Krause, L., Pryor, D., Thomas, J., Walpole, E. T., van der Gaast, A. and Smithers, M. (2018). Neoadjuvant therapy for esophageal adenocarcinoma: a propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapy. 43rd ESMO Congress (ESMO), Munich, Germany, 19-23 October 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdy282.015

Neoadjuvant therapy for esophageal adenocarcinoma: a propensity score-matched comparison of paclitaxel and carboplatin chemoradiotherapy with cisplatin and 5-fluoruracil-based chemo- or chemoradiotherapy

2017

Journal Article

Benchmarking complications associated with esophagectomy

Low, Donald E., Kuppusamy, Madhan Kumar, Alderson, Derek, Cecconello, Ivan, Chang, Andrew C, Darling, Gail, Davies, Andrew, D'Journo, Xavier Benoit, Gisbertz, Suzanne S, Griffin, S Michael, Hardwick, Richard, Hoelscher, Arnulf, Hofstetter, Wayne, Jobe, Blair, Kitagawa, Yuko, Law, Simon, Mariette, Christophe, Maynard, Nick, Morse, Christopher R, Nafteux, Philippe, Pera, Manuel, Pramesh, C S, Puig, Sonia, Reynolds, John V, Schroeder, Wolfgang, Smithers, Mark and Wijnhoven, B P L (2017). Benchmarking complications associated with esophagectomy. Annals of surgery, 269 (2), 1-298. doi: 10.1097/SLA.0000000000002611

Benchmarking complications associated with esophagectomy

2017

Journal Article

Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014

Aitken, Joanne F, Youlden, Danny R, Baade, Peter D, Soyer, H Peter, Green, Adèle C and Smithers, B Mark (2017). Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014. International journal of cancer, 142 (8), 1528-1535. doi: 10.1002/ijc.31141

Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014

2017

Journal Article

Whither melanoma in Australia?

Smithers, B. Mark, Dunn, Jeff and Soyer, H. Peter (2017). Whither melanoma in Australia?. Medical Journal of Australia, 207 (8), 330-331. doi: 10.5694/mja17.00740

Whither melanoma in Australia?

2017

Journal Article

Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study

Read, Tavis, Webber, Scott, Thomas, Janine, Wagels, Michael, Schaider, Helmut, Soyer, H. Peter and Smithers, B. Mark (2017). Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study. BMJ Open, 7 (10) e016816, 1-8. doi: 10.1136/bmjopen-2017-016816

Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study

2017

Journal Article

Associations of statins and diabetes with diagnosis of ulcerated cutaneous melanoma

von Schuckmann, Lena A., Smith, David, Hughes, Maria Celia B., Malt, Maryrose, van der Pols, Jolieke C., Khosrotehrani, Kiarash, Smithers, Bernard M. and Green, Adele C. (2017). Associations of statins and diabetes with diagnosis of ulcerated cutaneous melanoma. Journal of Investigative Dermatology, 137 (12), 2599-2605. doi: 10.1016/j.jid.2017.07.836

Associations of statins and diabetes with diagnosis of ulcerated cutaneous melanoma

2017

Journal Article

Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study

Kroon, Hidde M., Coventry, Brendon J., Giles, Mitchell H., Henderson, Michael A., Speakman, David, Wall, Mark, Barbour, Andrew, Serpell, Jonathan, Paddle, Paul, Smithers, Bernard M. and Thompson, John F. (2017). Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study. Annals of Surgical Oncology, 24 (11), 3245-3251. doi: 10.1245/s10434-017-6046-5

Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study

2017

Journal Article

The impact of smoking on sentinel node metastasis of primary cutaneous melanoma

Jones, Maris S., Jones, Peter C., Stern, Stacey L., Elashoff, David, Hoon, Dave S. B., Thompson, John, Mozzillo, Nicola, Nieweg, Omgo E., Noyes, Dirk, Hoekstra, Harald J., Zager, Jonathan S., Roses, Daniel F., Testori, Alessandro, Coventry, Brendon J., Smithers, Mark B., Andtbacka, Robert, Agnese, Doreen, Schultz, Erwin, Hsueh, Eddy C., Kelley, Mark, Schneebaum, Schlomo, Jacobs, Lisa, Bowles, Tawnya, Kashani-Sabet, Mohammed, Johnson, Douglas and Faries, Mark B. (2017). The impact of smoking on sentinel node metastasis of primary cutaneous melanoma. Annals of Surgical Oncology, 24 (8), 2089-2094. doi: 10.1245/s10434-017-5775-9

The impact of smoking on sentinel node metastasis of primary cutaneous melanoma

Supervision

Availability

Professor Mark Smithers is:
Not available for supervision

Supervision history

Current supervision

  • Master Philosophy

    Trends in the regional nodal management of cutaneous melanoma.

    Principal Advisor

    Other advisors: Professor Peter Soyer

  • Master Philosophy

    Retroperitoneal sarcoma: Impact of the patterns of care on patient outcomes in Queensland.

    Principal Advisor

    Other advisors: Professor Andrew Barbour

  • Master Philosophy

    Factors Influencing Anastomotic Complications after Oesophagectomy

    Associate Advisor

  • Doctor Philosophy

    Utilising the Multi-Disciplinary Resources at Tertiary Centres to Improve Outcomes from Pancreatic Cancer

    Associate Advisor

    Other advisors: Dr David Cavallucci

Completed supervision

Media

Enquiries

Contact Professor Mark Smithers directly for media enquiries about:

  • Advanced endoscopic surgery
  • Cancer surgery
  • Endoscopic surgery
  • General surgery
  • Melanoma
  • Surgery - cancer
  • Surgery - oesophageal, gastric cancer
  • Surgery - upper GI
  • Upper GI surgery

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au